Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0484-2026

BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; Recall

BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;

FDA recall Class II

Ongoing

FDA lists this Class II recall for BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0484-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 23, 2025
FDA report date
Nov 19, 2025
Quantity in commerce
29,760 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;

Affected model & UDI checker

Search the exact identifiers published for Z-0484-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
246100BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;Check source noticeNot specified
Not specifiedBD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;Check source notice30382902461006
FDA code information

Catalog No.: 246100; UDI-DI: 30382902461006; Lot Number: LM245590, LM245592, LM245593, LM245594, LM245666;

View the original FDA recall notice

Why was this product recalled?

The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used.

What actions did Becton Dickinson & Co. take?

On October 23, 2025 URGENT: Medical Device Correction letters were sent to customers. Actions for Clinical Users: 1. Immediately inspect your inventory for the specific catalog and lot numbers listed to determine if the lot in your possession is impacted and immediately discard any remaining inventory of the affected product. 2. *Note: Lot LM245666 has undergone rework and will be used as replacement material for affected product. Reworked inventory from this lot can be identified using the indicators described in ATTACHMENT 1- How to Identify Affected vs Reworked Product. Action to be taken by customer 1. Ensure the contents of this notification are read and understood. 2. Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology